Why a new health platform is a signal that healthcare executives need to rethink how consumers are motivated to live healthier lives.
Blue Shield of California’s rollout of a new digitally-based lifestyle medicine and health platform that can be personalized to each of its members’ individual health needs and preferences is a signal that healthcare executives need to rethink how consumers are motivated to live healthier lives.
The health plan's Wellvolution whole-health platform, created in collaboration with Solera Health, provides members guided on-demand access to a tailored network of clinically proven applications using lifestyle to prevent, treat, and even reverse disease. The program is available at no cost to members enrolled in Blue Shield's fully insured employer-sponsored plans or its individual and family plans.
Blue Shield's new platform gives its members access to a network of health-management and wellness resources that address:
“It’s clear that organizations are turning to mobile apps to support care and self-monitoring and further bridge the gap between consumers and medical professionals,” says Erin Fitzgerald, SVP of marketing at SERMO, a global social platform for physicians and healthcare professional survey company based in New York.
“Oftentimes, healthcare companies roll out siloed programs that have various barriers of entry,” she says. “Then, a meeting will be held once a year to go over resources and benefits only to be quickly forgotten. Because apps are a part of a consumer’s everyday life, this is a better approach to really integrate and promote workplace wellness in a more impactful and meaningful way. In fact, our platform has seen an uptick in the number of physicians discussing healthcare apps. Physicians are posting to get peer opinions on whether or not they should recommend certain healthcare applications to their own patients.”
Related: Patients Want Mobile Healthcare Options
Fitzgerald explains that partnerships will also be a key to moving forward.
“It’s not always about reinventing the wheel but leveraging what works and removing what doesn’t,” she says. “It’s also important for executives to listen to consumers and give them choices. Healthcare is not a one-size-fits-all industry, which we’ve experienced on our own platform. Some physicians use SERMO for crowdsourcing while others use it to participate in research or talk to peers. Additionally, marketing mobile apps to physicians is just as important as marketing them to consumers since there’s a lot of word-of-mouth and recommendations happening within the industry.”
With the recent release of Apple’s ECG app, SERMO surveyed its online community of 800,000 fully verified and licensed physicians to find out what physicians really think about the potential of mobile apps. Among other findings, data collected from 180 physicians revealed that:
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
FDA Approves Combination Therapy for Pulmonary Arterial Hypertension
March 26th 2024J&J’s Opsynvi is single-tablet combination of macitentan, an endothelin receptor antagonist, and tadalafil, a PDE5 inhibitor. It will be priced on parity with Opsumit, which is also a J&J product to treat patients with PAH.
Read More